76 related articles for article (PubMed ID: 36336972)
1. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway.
Qu Y; He Y; Ruan H; Qin L; Han Z
Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972
[TBL] [Abstract][Full Text] [Related]
2. Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.
Ge S; Wang K; Meng Y; He Z; Yang X; Shang W; Wang L
Med Oncol; 2023 Sep; 40(10):304. PubMed ID: 37733085
[TBL] [Abstract][Full Text] [Related]
3. DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway.
Guo W; Qu Y; Yu Y; Li X; Liang Z; Wang Z; Hu T; Zhou S
Aging (Albany NY); 2024 May; 16(10):9204-9215. PubMed ID: 38795388
[TBL] [Abstract][Full Text] [Related]
4. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
[TBL] [Abstract][Full Text] [Related]
5. Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma.
Ferreira Mendes JM; de Faro Valverde L; Torres Andion Vidal M; Paredes BD; Coelho P; Allahdadi KJ; Coletta RD; Souza BSF; Rocha CAG
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899449
[TBL] [Abstract][Full Text] [Related]
6. Potential targets of diosgenin for the treatment of oral squamous cell carcinoma and their bioinformatics and transcriptional profiling analyses.
Xiao Y; Xu B; Li X; Ding T; Zhao W; Nie X; Mu J; Xiao Z; Wang Q; Ren Q; Zhang E
Steroids; 2024 May; 205():109393. PubMed ID: 38458369
[TBL] [Abstract][Full Text] [Related]
7. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment.
Guo ZC; Jing SL; Jumatai S; Gong ZC
Cancer Immunol Immunother; 2023 Jun; 72(6):1523-1539. PubMed ID: 36513851
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma.
Shie WY; Cheng SJ; Chen KC; Tang CC; Peng HH; Ko HH; Hou HH; Elizabeth Chou HY
J Formos Med Assoc; 2024 Mar; 123(3):390-399. PubMed ID: 37704482
[TBL] [Abstract][Full Text] [Related]
9. The metabolic reprogramming of γ-aminobutyrate in oral squamous cell carcinoma.
Wu SL; Zha GY; Tian KB; Xu J; Cao MG
BMC Oral Health; 2024 Apr; 24(1):418. PubMed ID: 38580938
[TBL] [Abstract][Full Text] [Related]
10. TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK/JUN-mediated aerobic glycolysis.
Meng Z; Wang Y; Wang X; Han X
Arch Oral Biol; 2024 Aug; 164():105977. PubMed ID: 38696945
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the Genetic Web: H-Ras Expression and Mutation in Oral Squamous Cell Carcinoma-A Systematic Review.
Devi P; Dwivedi R; Sankar R; Jain A; Gupta S; Gupta S
Head Neck Pathol; 2024 Mar; 18(1):21. PubMed ID: 38502412
[TBL] [Abstract][Full Text] [Related]
12. Heat-killed Prevotella intermedia promotes the progression of oral squamous cell carcinoma by inhibiting the expression of tumor suppressors and affecting the tumor microenvironment.
Zhou Y; Qin Y; Ma J; Li Z; Heng W; Zhang L; Liu H; Li R; Zhang M; Peng Q; Ye P; Duan N; Liu T; Wang W; Wang X
Exp Hematol Oncol; 2024 Mar; 13(1):33. PubMed ID: 38515216
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and Potential Clinical Implications of Oral Microbiome in Oral Squamous Cell Carcinoma.
Wang J; Gao B
Curr Oncol; 2023 Dec; 31(1):168-182. PubMed ID: 38248096
[TBL] [Abstract][Full Text] [Related]
14. The potential mechanism of WT1-associated protein-induced N-6-methyladenosine modification of colony-stimulating factor 2 in the progression of oral squamous cell carcinoma by JAK/STAT3 pathway regulation.
Peng R; Jiang S; Jin Z
Eur J Oral Sci; 2024 Jun; ():e13001. PubMed ID: 38831514
[TBL] [Abstract][Full Text] [Related]
15. EHMT2 Suppresses ARRB1 Transcription and Activates the Hedgehog Signaling to Promote Malignant Phenotype and Stem Cell Property in Oral Squamous Cell Carcinoma.
Niu L; Hu G
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38573544
[TBL] [Abstract][Full Text] [Related]
16. KIF15 promotes the development and progression of chordoma via activating PI3K-AKT signalling pathway.
Yang J; Liu L; Xu X; Zeng H
Heliyon; 2024 Apr; 10(8):e29386. PubMed ID: 38681556
[TBL] [Abstract][Full Text] [Related]
17. Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma.
Yamanouchi R; Harada K; Ferdous T; Ueyama Y
Mol Clin Oncol; 2018 Mar; 8(3):400-406. PubMed ID: 29456845
[TBL] [Abstract][Full Text] [Related]
18. The Role of Single-Nucleotide Polymorphisms in the Function of Candidate Tumor Suppressor ALDH1L1.
Krupenko SA; Horita DA
Front Genet; 2019; 10():1013. PubMed ID: 31737034
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D-metabolizing enzyme CYP24A1 affects oncogenic behaviors of oral squamous cell carcinoma and its prognostic implication.
Nakamori Y; Takasawa A; Takasawa K; Kyuno D; Ono Y; Magara K; Nakahashi N; Sekiguchi S; Tsuchihashi K; Miyazaki A; Osanai M
Med Mol Morphol; 2024 May; ():. PubMed ID: 38772955
[TBL] [Abstract][Full Text] [Related]
20. Targeted down-regulation of SRSF1 exerts anti-cancer activity in OSCC through impairing lysosomal function and autophagy.
Qu Y; He Y; Wang Y; Han Z; Qin L
iScience; 2023 Dec; 26(12):108330. PubMed ID: 38025785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
